Bellerophon Therapeutics Inc's

• BLPH's Stock Performance relative to its Competitors

Zymeworks Inc Share Performance -12.04% Over The Past 5 Days

Zymeworks Inc Profile Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions. More about Zymeworks Inc 's Market Share

Phio Pharmaceuticals Corp Share Performance -6.31% Over The Past 5 Days

Phio Pharmaceuticals Corp Profile Phio Pharmaceuticals Corp's business model revolves around developing and commercializing innovative RNA-based therapeutics to treat various diseases and improve patient outcomes. More about Phio Pharmaceuticals Corp's Market Share

Oramed Pharmaceuticals Inc Share Performance +10.13% 30 Days

Oramed Pharmaceuticals Inc Profile Oramed Pharmaceuticals Inc. is a biopharmaceutical company with a business model focused on developing innovative oral drug delivery solutions. More about Oramed Pharmaceuticals Inc's Market Share

Oncternal Therapeutics Inc Share Performance -93.23% This Year

Oncternal Therapeutics Inc Profile Oncternal Therapeutics Inc's business model focuses on developing and commercializing novel therapies for the treatment of cancer. More about Oncternal Therapeutics Inc 's Market Share

Nextcure Inc Share Performance -4.46% Over The Past 5 Days

Nextcure Inc Profile NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need. More about Nextcure Inc 's Market Share

Sources: Bellerophon Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 13, 2026 8:39 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bellerophon Therapeutics inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.